Joint Formulary & PAD

Grazax (grass pollen) - Seasonal allergic hay fever (children)

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Oral lyophilisates
Associated Icons :
Restrictions / Comments :
Important
Licensed in children over 5 years of age.

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Grazax (grass pollen)
Indication :
Seasonal allergic hay fever (children)
Group Name :
Keywords :
Grass pollen extract, grass pollen allergy
Brand Names Include :
Grazax
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Grazax (grass pollen) is used to treat.

Other Drugs

Below are listed other drugs that are used to treat Seasonal allergic hay fever (children).

  • No records returned.

Committee Recommendations (2)

Traffic light status agreed / updated at the Surrey Heartlands APC as part of the Joint Formulary review.

Paediatric Grazax was considered and not routinely supported by the APC in Dec 2009 due to the lack of long term safety and efficacy data.